Lenalidomide Is Effective Treating Patients With Relapsed Multiple Myeloma and Very Severe Renal Impairment

被引：0
|
作者：
Joao, Cristina M.
Gomes, Fernando
Geraldes, Catarina
Parreira, Joana Maria
Neves, Manuel L.
Coelho, Ines
Esteves, Susana
Esteves, Graca V.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.5401.5401
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5401
引用
收藏
页数：2
相关论文
共 50 条
  • [11] LENALIDOMIDE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Okada, K.
    Okamoto, Y.
    Tsukamoto, T.
    Sugiura, H.
    Matsui, H.
    Ueda, T.
    Jo, T.
    Onishi, T.
    Kunitomi, A.
    Ueda, Y.
    ANNALS OF ONCOLOGY, 2013, 24
  • [12] Effectiveness of Lenalidomide in Patients with Relapsed or Progressive Multiple Myeloma
    Amor, A. A.
    Casanova, M.
    Fuertes, M.
    Guzman, J. L.
    Bueno, B. A.
    Giraldo, P.
    Canovas, A.
    Ibanez, A.
    Castillo, I.
    Blanes, M.
    Rios, E.
    Rodriguez, J. N.
    Palomera, L.
    Hernandez, M. T.
    Oriol, A.
    Sancho, E.
    Menchaca, C.
    Vercher, J.
    Gonzalez, A. P.
    Arilia, M. J.
    Ramirez, G.
    Perez, R.
    Asensio, A.
    de la Serna, J.
    Osorio, S.
    Aguilar, C.
    Anso, V.
    Calvo, J. M.
    Lopez, L.
    Lopez, A.
    Olalla, J. I.
    Hernandez, J. M.
    Petit, J.
    Rios, P.
    Villalon, L.
    Garcia, I.
    Garcia, A.
    Larregla, S.
    Garcia-Escribano, F. L.
    Lahuerta, J. J.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S17 - S18
  • [13] Repeated Lenalidomide Treatment in Patients With Relapsed Multiple Myeloma
    Stork, Martin
    Pour, Ludek
    Adam, Zdenek
    Krejci, Marta
    Sandecka, Viera
    Vaculova, Jitka
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E56 - E57
  • [14] Lenalidomide in relapsed patients with Multiple Myeloma - Focus on Polyneuropathy
    Goldschmidt, H.
    Heiss, C.
    Klein, U.
    Egerer, G.
    Raab, M. -S.
    Hillengass, J.
    Neben, K.
    ONKOLOGIE, 2011, 34 : 158 - 158
  • [15] Use of Lenalidomide May Surmount the Adverse Prognosis Induced by Renal Impairment In Patients (pts) with Relapsed/Refractory Multiple Myeloma (MM).
    Kleber, Martina
    Ihorst, Gabriele
    Udi, Josefina
    Koch, Bernd
    Engelhardt, Monika
    BLOOD, 2010, 116 (21) : 1253 - 1254
  • [16] Lenalidomide for the treatment of relapsed multiple myeloma
    Gajraj, Elangovan
    Chung, Helen
    Boysen, Meindert
    Barnett, David B.
    Longson, Carole
    LANCET ONCOLOGY, 2009, 10 (07): : 647 - 648
  • [17] An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment
    Dimopoulos, Meletios A.
    Mikhael, Joseph
    Terpos, Evangelos
    Leleu, Xavier
    Moreau, Philippe
    Blade, Joan
    Kim, Jin Seok
    Stockerl-Goldstein, Keith
    Richardson, Paul G.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [18] Efficacy and safety of dose-adjusted lenalidomide therapy in relapsed/refractory myeloma patients with renal impairment
    Ito, Shigeki
    Asahi, Maki
    Oyake, Tatsuo
    Izumida, Wataru
    Tsukushi, Yasuhiko
    Sugawara, Takeshi
    Ishida, Yoji
    ANNALS OF ONCOLOGY, 2015, 26 : 85 - 85
  • [19] Pharmacokinetics, safety, and efficacy of lenalidomide plus dexamethasone in patients with multiple myeloma and renal impairment
    Bridoux, Frank
    Chen, Nianhang
    Moreau, Stephane
    Arnulf, Bertrand
    Moumas, Eric
    Abraham, Julie
    Desport, Estelle
    Jaccard, Arnaud
    Fermand, Jean Paul
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (01) : 173 - 182
  • [20] Pharmacokinetics, safety, and efficacy of lenalidomide plus dexamethasone in patients with multiple myeloma and renal impairment
    Frank Bridoux
    Nianhang Chen
    Stephane Moreau
    Bertrand Arnulf
    Eric Moumas
    Julie Abraham
    Estelle Desport
    Arnaud Jaccard
    Jean Paul Fermand
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 173 - 182
12345